Joanna W. T.
- Country
- Poland
- Department
- Wojewódzkie Centrum Onkologii
Research Overview
- Pumitamig and Combination Therapy Versus Bevacizumab and Combination Therapy in Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
- A Phase 3, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (KEYNOTE-564)
- Phase III Randomized Trial of AZD0901 with Capecitabine ± Rilvegostomig in First‑Line Claudin‑18.2‑Positive HER2‑Negative Advanced Gastric, GEJ or Esophageal Adenocarcinoma
Data & Insights
Has run more than one trial at 305 of 555 partner sites.
Specializations
Urological Oncology
Specialized in treating various forms of renal cell carcinoma, including advanced and metastatic cases. Conducts research on novel therapeutic approaches for urothelial cancer and metastatic castration-resistant prostate cancer.
- Advanced Renal Cell Carcinoma
- Metastatic Urothelial Cancer
- Prostate Cancer Management
Gastrointestinal Oncology
Focuses on innovative treatments for hepatocellular carcinoma, colorectal cancer, and gastric cancer. Particular expertise in treating BRAF-mutant colorectal cancer and CLDN18.2-expressing gastric cancers.
- Advanced Hepatocellular Carcinoma
- Genetic Mutation-Specific Colorectal Cancer
- Gastroesophageal Junction Adenocarcinoma
Other Oncological Specialties
Experience in treating breast cancer, melanoma, and non-small cell lung cancer. Particular focus on hormone receptor-positive breast cancer and advanced melanoma management.
- ER-Positive/HER2-Negative Breast Cancer
- Advanced Melanoma
- Metastatic Lung Cancer
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.